Europe Electroceuticals Market Size & Growth (2019 - 2024)
As per the research report, the size of the Europe Electroceuticals Market is valued at USD 5.2 billion in 2019 and estimated to be growing at a CAGR of 7.4%, to reach USD 7.43 billion by 2024 during the forecast period 2019-2024.
Electroceuticals utilize medical devices to modulate body's neural circuits as an alternative to drug-based intervention.
Electroceuticals, also referred as bioelectric medicines utilize combination of molecular medicine, bio-engineering and neuroscience to develop nerve stimulating and sensing technologies to regulate biological processes and disease treatment. It helps treating diseases like Epilepsy where conventional drugs aren’t effective in tackling it. Epilepsy is directly caused by an electrical malfunction of the brain. This common neurological disease affects more than 50 million people worldwide.
Factors accountable to drive the market are growing geriatric population, increasing financial expenditure on R and D to develop novel and innovative therapies and devices, rise in prevalence of neural diseases among the aging population like Alzheimer’s and Parkinson’s disease and regulatory approvals for new and advanced electroceuticals. However, factors like expensive nature of products and low awareness among individuals are the factors hindering the growth of market.
This research report segmented and sub-segmented into the following categories:
U.K. is leading the market regionally, due to presence of developed healthcare system as well as presence of market leaders. Germany is expected to grow the fastest owing to its increasing disposable income, growing government initiatives to develop healthcare infrastructure and increasing awareness. Implantable devices have held the major share in the market due to prevalence of neurological diseases while non implantable devices are expected to grow at a higher CAGR. The hospitals segment is expected to account for the largest share of the market in 2016 while, the individual users segment is projected to grow at the highest CAGR in the forecast period.
Key players operating in the Europe Electroceuticals Market profiled in this report are Medtronic plc, St. Jude Medical, Inc., Boston Scientific Corporation, Cochlear Limited, Sonova Holding AG, LivaNova PLC, Biotronik, Nevro Corporation, Second Sight Medical Products, Inc., and ElectroCore LLC.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Implantable Cardioverter Defibrillators
5.1.3 Cardiac Pacemakers
5.1.4 Spinal Cord Stimulators
5.1.5 Cochlear Implants
5.1.6 Deep Brain Stimulators
5.1.7 Transcutaneous Electrical Nerve Stimulators
5.1.8 Vagus Nerve Stimulators
5.1.9 Sacral Nerve Stimulators
5.1.10 Retinal Implants
5.1.11 Other Electrical Stimulators
5.1.12 Y-o-Y Growth Analysis, By Product
5.1.13 Market Attractiveness Analysis, By Product
5.1.14 Market Share Analysis, By Product
5.2 Type of Devices
5.2.1 Introduction
5.2.2 Implantable Electroceutical Devices
5.2.3 Non-Invasive Electroceutical Devices
5.2.4 Y-o-Y Growth Analysis, By Type of Devices
5.2.5 Market Attractiveness Analysis, By Type of Devices
5.2.6 Market Share Analysis, By Type of Devices
5.3 Application
5.3.1 Introduction
5.3.2 Arrhythmia
5.3.3 Chronic Back Pain
5.3.4 Failed Back Syndrome
5.3.5 Ischemia
5.3.6 Sensorineural Hearing Loss
5.3.7 Parkinson’s Disease
5.3.8 Tremor
5.3.9 Alzheimer's disease
5.3.10 Depression
5.3.11 Migraine
5.3.12 Epilepsy
5.3.13 Other Applications
5.3.14 Y-o-Y Growth Analysis, By Application
5.3.15 Market Attractiveness Analysis, By Application
5.3.16 Market Share Analysis, By Application
5.4 End-Users
5.4.1 Introduction
5.4.2 Hospitals
5.4.3 Research Institutes
5.4.4 Individual Users
5.4.5 Y-o-Y Growth Analysis, By End-Users
5.4.6 Market Attractiveness Analysis, By End-Users
5.4.7 Market Share Analysis, By End-Users
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type of Devices
6.1.3.4 By Application
6.1.3.5 By End-Users
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Type of Devices
6.1.4.4 By Application
6.1.4.5 By End-Users
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Type of Devices
6.1.5.4 By Application
6.1.5.5 By End-Users
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Medtronic plc
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 St. Jude Medical, Inc.
8.3 Boston Scientific Corporation
8.4 Cochlear Limited
8.5 Sonova Holding AG
8.6 LivaNova PLC
8.7 Biotronik
8.8 Nevro Corporation
8.9 Second Sight Medical Products, Inc.
8.10 ElectroCore LLC
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
